Coadministration of doxorubicin and etoposide loaded in camel milk phospholipids liposomes showed increased antitumor activity in a murine model

References

• MinottiGMennaPSalvatorelliECairoGGianniLAnthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicityPharmacol Rev200456218522915169927
   PubMed Web of Science ®Google Scholar
• WangDLippardSJCellular processing of platinum anticancer drugsNat Rev Drug Discov20054430732015789122
   PubMed Web of Science ®Google Scholar
• JiaJZhuFMaXCaoZLiYChenYZMechanisms of drug combinations: interaction and network perspectivesNat Rev Drug Discov20098211112819180105
   PubMed Web of Science ®Google Scholar
• NitissJLTargeting DNA topoisomerase II in cancer chemotherapyNat Rev Cancer20099533835019377506
   PubMed Web of Science ®Google Scholar
• KellandLThe resurgence of platinum-based cancer chemotherapyNat Rev Cancer20077857358417625587
   PubMed Web of Science ®Google Scholar
• MartoniABelluccoACanovaNPannutiFFour-year analysis of platinum and anthracycline combination for ovarian cancerOncology19894621091162710475
   PubMed Web of Science ®Google Scholar
• NielsenOSDombernowskyPMouridsenHEpirubicin is not superior to doxorubicin in the treatment of advanced soft tissue sarcomas. The experience of the EORTC Soft Tissue and Bone Sarcoma GroupSarcoma200041–2313518521432
   PubMedGoogle Scholar
• ThigpenJTBradyMFHomesleyHDPhase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group studyJ Clin Oncol200422193902390815459211
   PubMed Web of Science ®Google Scholar
• BigioniMBenzoAIrrissutoCAntitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograftCancer Chemother Pharmacol200862462162918038274
   PubMed Web of Science ®Google Scholar
• ChouTCTalalayPAnalysis of combined drug effects: a new look at a very old problemTrends Pharmacol Sci19834450454
   Web of Science ®Google Scholar
• ChouTCTalalayPQuantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdv Enzyme Regul19842227556382953
   PubMedGoogle Scholar
• ChouTCDrug combination studies and their synergy quantification using the Chou-Talalay methodCancer Res201070244044620068163
   PubMed Web of Science ®Google Scholar
• BerenbaumMCWhat is synergy?Pharmacol Rev1989412931412692037
   PubMed Web of Science ®Google Scholar
• ZhaoLWientjesMGAuJLEvaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analysesClin Cancer Res200410237994800415585635
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
   PubMed Web of Science ®Google Scholar
• BlumeGCevcGLiposomes for the sustained drug release in vivoBiochim Biophys Acta19901029191972223816
   PubMed Web of Science ®Google Scholar
• WoodleMCLasicDDSterically stabilized liposomesBiochim Biophys Acta1992111321711991510996
   PubMed Web of Science ®Google Scholar
• LasicDDMartinFJGabizonAHuangSKPapahadjopoulosDSterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation timesBiochim Biophys Acta1991107011871921751525
   PubMed Web of Science ®Google Scholar
• GabizonAASelective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomesCancer Res19925248918961737351
   PubMed Web of Science ®Google Scholar
• GabizonAPapahadjopoulosDLiposome formulations with prolonged circulation time in blood and enhanced uptake by tumorsProc Natl Acad Sci U S A19888518694969533413128
   PubMed Web of Science ®Google Scholar
• GabizonAShiotaRPapahadjopoulosDPharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation timesJ Natl Cancer Inst19898119148414882778836
   PubMedGoogle Scholar
• GabizonAPriceDCHubertyJBresalierRSPapahadjopoulosDEffect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studiesCancer Res19905019637163781698120
   PubMed Web of Science ®Google Scholar
• KlibanovALMaruyamaKTorchilinVPHuangLAmphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Lett199026812352372384160
   PubMed Web of Science ®Google Scholar
• SeniorJDelgadoCFisherDTilcockCGregoriadisGInfluence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesiclesBiochim Biophys Acta19911062177821998713
   PubMed Web of Science ®Google Scholar
• AllenTMAustinGAChonnALinLLeeKCUptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and sizeBiochim Biophys Acta19911061156641995057
   PubMed Web of Science ®Google Scholar
• KonuspayevaGFayeBLoiseauGThe composition of camel milk: a meta-analysis of the literature dataJ Food Compos Anal20082295101
   Web of Science ®Google Scholar
• MaswadehHMAljarbouANAlorainyMSAlsharidahMSKhanMAEtoposide incorporated into camel milk phospholipids liposomes shows increased activity against fibrosarcoma in a mouse modelBio Med Research Int201511 http://dx.doi.org/10.1155/2015/743051
   Google Scholar
• HwangTLLeeWRHuaSCFangJYCisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomasJ Dermatol Sci2007461112017267180
   PubMed Web of Science ®Google Scholar
• KhanAKhanAADwivediVAhmadMGHakeemSOwaisMTuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino miceMol Med2007135–626627617622310
   PubMed Web of Science ®Google Scholar
• ChowLMBakerSJPTEN function in normal and neoplastic growthCancer Lett2006241218419616412571
   PubMed Web of Science ®Google Scholar
• MayoLDDonnerDBThe PTEN, Mdm2, p53 tumor suppressor-oncoprotein networkTrends Biochem Sci200227946246712217521
   PubMed Web of Science ®Google Scholar
• RahmaniAAlzohairyMBabikerAYRizviMAElkarimahmadHGClinicopathological significance of PTEN and bcl2 expressions in oral squamous cell carcinomaInt J Clin Exp Pathol20125996597123119114
   PubMed Web of Science ®Google Scholar